Highly attuned to regulatory changes affecting the capital market in Hong Kong, in part due to several senior members’ former high-ranking in-house regulatory roles, Slaughter and May consistently ‘delivers high-quality work’ to issuers and sponsors/underwriters on often very challenging listings and secondary offerings. The team also handles a considerable amount of standalone capital markets regulatory work, including its recent work for industry association Asia Securities Industry and Financial Markets Association (ASIFMA) on its interactions with the HKEX to help shape the new listing regime in Hong Kong for Specialist Technology Companies, which is now in force. Clara Choi and John Moore have a ’deep and solid understanding of the market’, with the former particularly skilled at advising blue chip companies on the spin-offs of their subsidiaries in Hong Kong. Moore co-heads the team alongside the vastly experienced Benita Yu.
Testimonials
Collated independently by Legal 500 research team.
- 'The team delivers consistently high-quality work.'
- 'Clara Choi and John Moore are commercial and experienced practitioners with a deep and solid understanding of the market.'
Key clients
- Asia Securities Industry and Financial Markets Association
- BVCF Management Ltd.
Work highlights
- Advised Dekon Group, a PRC-based livestock and poultry breeding and farming enterprise, on its IPO and listing on the HKEX.
- Advising Sunshine Lake Pharma on the proposed privatisation of its HKEX-listed subsidiary, YiChang HEC and the listing on the HKEX of Sunshine Lake Pharma. This will be the first ever merger by absorption followed by a listing by introduction of the offeror in Hong Kong.